PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Regulatory News (HVO)

Share Price Information for hVIVO (HVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 27.00
Ask: 28.00
Change: 0.25 (0.92%)
Spread: 1.00 (3.704%)
Open: 27.25
High: 27.50
Low: 27.25
Prev. Close: 27.25
HVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Interest in Shares

26 Jun 2013 07:00

RNS Number : 8532H
Retroscreen Virology Group PLC
26 June 2013
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Retroscreen Virology Group plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

 X

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

 

 

Henderson Global Investors

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date on which the threshold is crossed or reached:

 

 24 June 2013

6. Date on which issuer notified:

 

 25 June 2013

7. Threshold(s) that is/are crossed or reached:

 

 Below 5%

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 ORD GBP0.05

2,099,414

2,099,414

1,949,414

4.75%

 GB00B6ZM0X53

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Expirationdate

Exercise/ConversionPeriod

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 

Nominal

Delta

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

1,949,414

4.75%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

 

Proxy Voting:

 

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

 

 Cate Hex-Candy

15. Contact telephone number:

 

 0207 818 2156

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFAMRTMBMTBFJ
Date   Source Headline
21st Feb 20174:30 pmRNSInitiation of a Phase I clinical trial with AGS-v
9th Feb 20177:00 amRNSData from PrEP Biopharm's Ph. IIa clinical studies
5th Jan 20177:00 amRNSDirectors' Dealings
30th Dec 20167:00 amRNSChange of auditor
27th Oct 20167:00 amRNSNotification of Major Interest in Shares
12th Oct 20167:00 amRNSDirectors' Dealings
23rd Sep 20167:00 amRNSExercise of Share Options
22nd Sep 20167:00 amRNSHalf-year Report
21st Sep 20167:00 amRNSTrading Update
8th Sep 20167:00 amRNSNotification of Major Interest in Shares
2nd Sep 20167:00 amRNShVIVO Landmark Asthma Study Underway
4th Aug 20167:00 amRNSDirectors' Dealings
12th Jul 201612:45 pmRNSNotification of Major Interest in Shares
14th Jun 201612:00 pmRNSFavourable results for PrEP Biopharm's Flu Study
24th May 20167:00 amRNSDavid Norwood Lock-in Deed
23rd May 201612:00 pmRNSResult of AGM
28th Apr 20162:05 pmRNS2015 Annual Report and Financial Statements
27th Apr 20167:00 amRNSNotification of Major Interest in Shares
25th Apr 20167:00 amRNSInitial results for PrEP Biopharm's Flu study
22nd Apr 20167:00 amRNSJoint Venture Investment with the SEEK Group
21st Apr 201611:43 amRNSNotification of Major Interest in Shares
20th Apr 20167:01 amRNSBoard Changes
20th Apr 20167:00 amRNS2015 Audited Preliminary Results
14th Apr 20167:00 amRNSDirectors' Dealings
16th Mar 20169:32 amRNSNotification of Major Interest in Shares
6th Jan 20167:00 amRNSDirectors' Dealings
18th Dec 20157:00 amRNSNotification of Major Interest in Shares
17th Dec 20152:00 pmRNSNotification of Major Interest in Shares
17th Dec 20157:00 amRNSNotification of Major Interest in Shares
15th Dec 20152:00 pmRNSResult of General Meeting
30th Nov 20157:00 amRNSNotification of Major Interest in Shares
26th Nov 20157:00 amRNSConditional Placing to raise £20.5 million
2nd Nov 20157:01 amRNSTrading Update
2nd Nov 20157:00 amRNShVIVO invests in PrEP Biopharm Limited
5th Oct 20152:00 pmRNSDirectors' Dealings
24th Sep 20157:00 amRNSHalf Yearly Report
6th Jul 20157:00 amRNSDirectors' Dealings
25th Jun 20152:00 pmRNSExercise of Share Options
8th Jun 20154:35 pmRNSPrice Monitoring Extension
4th Jun 20154:40 pmRNSSecond Price Monitoring Extn
4th Jun 20154:35 pmRNSPrice Monitoring Extension
29th May 20157:00 amRNSNotification of Major Interest in Shares
26th May 201512:00 pmRNSResult of AGM
14th May 20157:00 amRNSDirector's Dealings
13th May 20157:00 amRNSExercise of Share Options
8th May 20157:00 amRNSDirector's Dealings
30th Apr 20156:26 pmRNSDirector's Dealings
24th Apr 20152:00 pmRNS2014 Annual Report and Financial Statements
21st Apr 20153:43 pmRNSAward of Share Options
16th Apr 20157:01 amRNS2014 Audited Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.